No records
|
551 |
Turana Y., Tengkawan J., Chia Y.C., Shin J., Chen C.-H., Park S., Tsoi K., Buranakitjaroen P., Soenarta A.A., Siddique S., Cheng H.-M., Tay J.C., Teo B.W., Wang T.-D., Kario K. |
56083326000;57201472878;57204080905;54791393300;7501963868;8556278400;16065259000;6603376248;6507634613;57210091066;57026688600;24330212600;23570166200;7405566618;7102633390; |
Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
504 |
512 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097219445&doi=10.1111%2fjch.14121&partnerID=40&md5=67d4846f474282e2b6bd32d52a692db9 |
School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong; Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Punjab Medical Center, Lahore, Pakistan; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Center for Evidence-Based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Public Health, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei City, Taiwan; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan |
Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Tengkawan, J., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Chia, Y.C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Chen, C.-H., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Park, S., Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Tsoi, K., JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong; Buranakitjaroen, P., Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Cheng, H.-M., Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Center for Evidence-Based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Institute of Public Health, National Yang-Ming University School of Medicine, Taipei, Taiwan; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Teo, B.W., Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Wang, T.-D., Department of Internal Medicine, National Taiwan University College of Medicine, Taipei City, Taiwan; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan |
The “triple burden” of aging population, hypertension, and mental health problems making elderly in Asia is more vulnerable. There is evidence of a bidirectional relationship between mental health and hypertension, which results in lower quality of life, lower rate of treatment adherence, and higher mortality among elderly individuals. It is essential to overcome known barriers and care for the elderly with high-risk factors in order to address these burdens. This review revealed that elderly with hypertension were more likely to suffer from depression and anxiety. Therefore, debunking myths, creating awareness regarding mental health, and increasing access to mental health resources through holistic community-based programs would greatly reduce such problems and optimize the chances of success in controlling hypertension-related problems. © 2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC |
Asia; elderly; hypertension; mental health |
antihypertensive agent; aged; anxiety; Asia; cardiovascular disease; cerebrovascular disease; community mental health service; comorbidity; depression; disease association; disease burden; elderly care; health care access; high risk population; human; hypertension; late life depression; life stress; loneliness; medication compliance; mental disease; mental health; motivation; patient compliance; Review; anxiety disorder; hypertension; mental health; quality of life; Aged; Anxiety Disorders; Asia; Humans; Hypertension; Mental Health; Quality of Life |
John Wiley and Sons Inc |
15246175 |
|
33283971 |
Review |
Q2 |
909 |
5078 |
|
|
552 |
Chang H.-C., Cheng H.-M., Chen C.-H., Wang T.-D., Soenarta A.A., Turana Y., Teo B.W., Tay J.C., Tsoi K., Wang J.-G., Kario K. |
57208131716;57026688600;7501963868;7405566618;6507634613;56083326000;23570166200;24330212600;16065259000;57211730247;7102633390; |
Dietary intervention for the management of hypertension in Asia |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
538 |
544 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097029615&doi=10.1111%2fjch.14116&partnerID=40&md5=dd0dddd11a11196e4a83b9fd85ea06f2 |
Department of Medicine, Taipei Veterans General Hospital Su-Ao and Yuan-Shan Branch, Yilan, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Division of Cardiology, National Taiwan University Hospital, Taipei, Taiwan; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan |
Chang, H.-C., Department of Medicine, Taipei Veterans General Hospital Su-Ao and Yuan-Shan Branch, Yilan, Taiwan; Cheng, H.-M., Department of Medicine, Taipei Veterans General Hospital Su-Ao and Yuan-Shan Branch, Yilan, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Chen, C.-H., Department of Medicine, Taipei Veterans General Hospital Su-Ao and Yuan-Shan Branch, Yilan, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Wang, T.-D., Division of Cardiology, National Taiwan University Hospital, Taipei, Taiwan; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Teo, B.W., Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Tsoi, K., JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan |
Hypertension is among the leading global risks for premature death. As the risks substantially increase along with the elevated blood pressure, a small reduction of blood pressure could have prevented numerous cardiovascular events in general population. Evidence has shown that dietary intervention is a cost-effective strategy that has been broadly advocated in the published guidelines. However, the implementation could be limited by different food cultures. This review details the mechanisms of each dietary intervention approach, evidence, and the implications in Asian populations, and the perspective of future research. © 2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC |
dietary intervention; hypertension |
aldosterone; calcium; catecholamine; magnesium; potassium; renin; Asia; blood pressure regulation; body weight loss; calcium blood level; caloric restriction; cardiovascular risk factor; cost effectiveness analysis; cultural anthropology; DASH diet; diastolic blood pressure; diet supplementation; diet therapy; dietary pattern; disease association; electrolyte intake; evidence based medicine; fluid retention; food security; human; hyperinsulinemia; hypertension; ideal body weight; insulin resistance; lifestyle modification; magnesium blood level; Mediterranean diet; mortality; obesity; potassium blood level; potassium intake; practice guideline; renin angiotensin aldosterone system; Review; sodium restriction; sodium retention; sodium transport; sodium urine level; systolic blood pressure; |
John Wiley and Sons Inc |
15246175 |
|
33274585 |
Review |
Q2 |
909 |
5078 |
|
|
553 |
Turana Y., Tengkawan J., Chia Y.C., Nathaniel M., Wang J.-G., Sukonthasarn A., Chen C.-H., Minh H.V., Buranakitjaroen P., Shin J., Siddique S., Nailes J.M., Park S., Teo B.W., Sison J., Ann Soenarta A., Hoshide S., Tay J.C., Prasad Sogunuru G., Zhang Y., Verma N., Wang T.-D., Kario K., the HOPE Asia Network |
56083326000;57201472878;57204080905;57220063330;57211730247;12793132900;7501963868;57211946145;6603376248;54791393300;57210091066;57204676117;8556278400;23570166200;36764809200;56545726300;6603859769;24330212600;57220061819;56183109800;7102496979;7405566618;7102633390; |
Hypertension and stroke in Asia: A comprehensive review from HOPE Asia |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
513 |
521 |
|
5 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096667710&doi=10.1111%2fjch.14099&partnerID=40&md5=85c747eb49b66c56895a7650e9a82984 |
School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Cardiology, Hue University Hospital, Hue University, Hue City, Viet Nam; Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Punjab Medical Center, Lahore, Pakistan; University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines; Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Division of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore; Division of Nephrology, Department of Medicine, National University Health System, Singapore City, Singapore; Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Physiology, King George's Medical University, Lucknow, India; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan |
Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Tengkawan, J., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Chia, Y.C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Nathaniel, M., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Sukonthasarn, A., Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Chen, C.-H., Department of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan; Minh, H.V., Department of Cardiology, Hue University Hospital, Hue University, Hue City, Viet Nam; Buranakitjaroen, P., Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Nailes, J.M., University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines; Park, S., Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Teo, B.W., Division of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore, Division of Nephrology, Department of Medicine, National University Health System, Singapore City, Singapore; Sison, J., Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines; Ann Soenarta, A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Prasad Sogunuru, G., MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Zhang, Y., Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Verma, N., Department of Physiology, King George's Medical University, Lucknow, India; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; the HOPE Asia Network |
Stroke is the primary cause of disability and vascular death worldwide, including Asia. Asian characteristics that differ from the West lead to higher stroke incidence. Stroke epidemiology studies in Asia have shown varying levels of mortality, incidence, prevalence, and burden of disease. Hypertension is the most prevalent risk factor found in Asia. Besides ethnicity that is associated with stroke incidence, both systolic blood pressure, diastolic blood pressure, and blood pressure variability are positively correlated with stroke incidence. Post-stroke cognitive impairment is one of the sequelae that affect one-third of stroke survivors and has become a significant public health concern that is often neglected despite its increasing prevalence. Therefore, it is very important to prevent recurrence by treating stroke optimally and effectively. Increasing awareness and treatment adherence to hypertension, the leading risk factor for stroke, became the main goal in several countries in Asia. © 2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. |
Asia; hypertension; stroke |
Asia; awareness; blood pressure variability; cerebrovascular accident; clinical effectiveness; dementia; diastolic blood pressure; disease burden; global health; human; hypertension; incidence; medication compliance; mortality rate; post stroke dementia; prevalence; recurrent disease; Review; risk factor; systolic blood pressure; blood pressure; cerebrovascular accident; hypertension; Asia; Blood Pressure; Humans; Hypertension; Incidence; Risk Factors; Stroke |
John Wiley and Sons Inc |
15246175 |
|
33190399 |
Review |
Q2 |
909 |
5078 |
|
|
554 |
Ross J., Jiamsakul A., Kumarasamy N., Azwa I., Merati T.P., Do C.D., Lee M.P., Ly P.S., Yunihastuti E., Nguyen K.V., Ditangco R., Ng O.T., Choi J.Y., Oka S., Sohn A.H., Law M. |
57193109926;55285745500;7003549856;55553159100;57203678680;56658396600;56143671100;9743902800;57221273925;56370854300;55406840800;57203665233;48761023600;57216171596;7006405275;57222965808; |
Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific |
2021 |
HIV Medicine |
22 |
3 |
|
201 |
211 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096661480&doi=10.1111%2fhiv.13006&partnerID=40&md5=9ef6bceb9ed5dc756f178320119cc3c4 |
TREAT Asia/amfAR –The Foundation for AIDS Research, Bangkok, Thailand; The Kirby Institute, UNSW Sydney, Kensington, NSW, Australia; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India; Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Faculty of Medicine Udayana University & Sanglah Hospital, Bali, Indonesia; Bach Mai Hospital, Hanoi, Viet Nam; Queen Elizabeth Hospital, Hong Kong; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia; Faculty of Medicine, Universitas Indonesia - Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; National Hospital for Tropical Diseases, Hanoi, Viet Nam; Research Institute for Tropical Medicine, Muntinlupa City, Philippines; Tan Tock Seng Hospital, Singapore, Singapore; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; National Center for Global Health and Medicine, Tokyo, Japan |
Ross, J., TREAT Asia/amfAR –The Foundation for AIDS Research, Bangkok, Thailand; Jiamsakul, A., The Kirby Institute, UNSW Sydney, Kensington, NSW, Australia; Kumarasamy, N., Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India; Azwa, I., Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Merati, T.P., Faculty of Medicine Udayana University & Sanglah Hospital, Bali, Indonesia; Do, C.D., Bach Mai Hospital, Hanoi, Viet Nam; Lee, M.P., Queen Elizabeth Hospital, Hong Kong; Ly, P.S., National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia; Yunihastuti, E., Faculty of Medicine, Universitas Indonesia - Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Nguyen, K.V., National Hospital for Tropical Diseases, Hanoi, Viet Nam; Ditangco, R., Research Institute for Tropical Medicine, Muntinlupa City, Philippines; Ng, O.T., Tan Tock Seng Hospital, Singapore, Singapore; Choi, J.Y., Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; Oka, S., National Center for Global Health and Medicine, Tokyo, Japan; Sohn, A.H., TREAT Asia/amfAR –The Foundation for AIDS Research, Bangkok, Thailand; Law, M., The Kirby Institute, UNSW Sydney, Kensington, NSW, Australia |
Objectives: To assess second-line antiretroviral therapy (ART) virological failure and HIV drug resistance-associated mutations (RAMs), in support of third-line regimen planning in Asia. Methods: Adults > 18 years of age on second-line ART for ≥ 6 months were eligible. Cross-sectional data on HIV viral load (VL) and genotypic resistance testing were collected or testing was conducted between July 2015 and May 2017 at 12 Asia-Pacific sites. Virological failure (VF) was defined as VL > 1000 copies/mL with a second VL > 1000 copies/mL within 3–6 months. FASTA files were submitted to Stanford University HIV Drug Resistance Database and RAMs were compared against the IAS-USA 2019 mutations list. VF risk factors were analysed using logistic regression. Results: Of 1378 patients, 74% were male and 70% acquired HIV through heterosexual exposure. At second-line switch, median [interquartile range (IQR)] age was 37 (32–42) years and median (IQR) CD4 count was 103 (43.5–229.5) cells/µL; 93% received regimens with boosted protease inhibitors (PIs). Median duration on second line was 3 years. Among 101 patients (7%) with VF, CD4 count > 200 cells/µL at switch [odds ratio (OR) = 0.36, 95% confidence interval (CI): 0.17–0.77 vs. CD4 ≤ 50) and HIV exposure through male–male sex (OR = 0.32, 95% CI: 0.17–0.64 vs. heterosexual) or injecting drug use (OR = 0.24, 95% CI: 0.12–0.49) were associated with reduced VF. Of 41 (41%) patients with resistance data, 80% had at least one RAM to nonnucleoside reverse transcriptase inhibitors (NNRTIs), 63% to NRTIs, and 35% to PIs. Of those with PI RAMs, 71% had two or more. Conclusions: There were low proportions with VF and significant RAMs in our cohort, reflecting the durability of current second-line regimens. © 2020 British HIV Association |
Asia; drug resistance; HIV; second-line antiretroviral therapy; virological failure |
anti human immunodeficiency virus agent; emtricitabine; Human immunodeficiency virus proteinase inhibitor; integrase inhibitor; lamivudine; lopinavir; nonnucleoside reverse transcriptase inhibitor; raltegravir; RNA directed DNA polymerase inhibitor; tenofovir; adult; antiretroviral therapy; antiviral resistance; Article; Cambodia; CD4 lymphocyte count; cohort analysis; comparative study; cross-sectional study; data base; female; gene mutation; genotyping technique; heterosexuality; Hong Kong; human; Human immunodeficiency virus; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; India; Indonesia; injection drug user; Japan; major clinical study; Malaysia; male; men who have sex with men; middle aged; Philippines; priority journal; prospective study; retr |
Blackwell Publishing Ltd |
14642662 |
|
33151020 |
Article |
Q1 |
1530 |
2201 |
|
|
555 |
Susanto A.D., Winardi W., Hidayat M., Wirawan A. |
57190425587;57211654146;56435992700;57221412258; |
The use of indoor plant as an alternative strategy to improve indoor air quality in Indonesia |
2021 |
Reviews on Environmental Health |
36 |
1 |
|
95 |
99 |
|
3 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094149752&doi=10.1515%2freveh-2020-0062&partnerID=40&md5=a7a8a53669f01afb3fc072e87f174a11 |
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jl. Persahabatan Raya No.1, Jakarta, 13230, Indonesia; Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Mataram, Mataram, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jakarta, Indonesia |
Susanto, A.D., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jl. Persahabatan Raya No.1, Jakarta, 13230, Indonesia; Winardi, W., Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Hidayat, M., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Mataram, Mataram, Indonesia; Wirawan, A., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jakarta, Indonesia |
Indoor air pollution marked with decreased air quality below the set standard. The quality of indoor air is determined by ambient air quality as well as by a harmful substance resulting from the household activity. Indoor air pollution may cause several problems such as sick building syndrome, chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and is responsible for nearly two million death in developing countries. One of the interesting research topics to overcome the indoor air pollution problem is the application of indoor plants. Although there are no established criteria to specify the best indoor plant, several studies have revealed the capability of a particular indoor plant to remove the harmful substances. This paper summarizes important information about indoor air pollution and provides the evidence-based insight of indoor plant usefulness as an alternative way for indoor air remediation. © 2021 De Gruyter. All rights reserved. |
Air pollution; Air quality; Indoor air pollution |
ecosystem restoration; human; Indonesia; indoor air pollution; plant; prevention and control; procedures; Air Pollution, Indoor; Environmental Restoration and Remediation; Humans; Indonesia; Plants |
De Gruyter Open Ltd |
00487554 |
|
32920542 |
Review |
Q2 |
644 |
7826 |
|
|
556 |
Ariestine D.A., Sari N.K., Rinaldi I., Abdullah M. |
57219412521;57209884078;23475122400;7103393434; |
Quality of life in older survivors of non-Hodgkin's lymphoma who received chemotherapy and related factors |
2021 |
Journal of Geriatric Oncology |
12 |
2 |
|
326 |
331 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092628404&doi=10.1016%2fj.jgo.2020.09.002&partnerID=40&md5=92d66bbff89e86b5c41bc8d40476f78e |
Division of Geriatric Medicine, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Indonesia; Division of Geriatric Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia; National Cancer Center-Dharmais Cancer Hospital, Jakarta, Indonesia; Division of Hemato-oncolocy, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Indonesia; Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Indonesia |
Ariestine, D.A., Division of Geriatric Medicine, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Indonesia, Division of Geriatric Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia; Sari, N.K., Division of Geriatric Medicine, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Indonesia, National Cancer Center-Dharmais Cancer Hospital, Jakarta, Indonesia; Rinaldi, I., Division of Hemato-oncolocy, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Indonesia; Abdullah, M., Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Indonesia |
Introduction: Cancer and its treatment have a broad impact on patients' Quality of Life (QoL). Previous researches showed that many factors in Comprehensive Geriatric Assessment (CGA) affect QoL. CGA could predict toxicity, overall survival rate and can help adjust the choice and intensity of treatment in each patient. However, there has been no research explicitly exploring factors related to the QoL in older patients with Non-Hodgkin's Lymphoma (NHL). This research aims to explore the how factors in CGA relate to the QoL in older patients with NHL. Materials and Method: The study design was cross-sectional in NHL patients aged ≥ 60 years, research was conducted in Integrated Geriatric Polyclinic and Hemato-Oncology Polyclinic of three public hospitals in Jakarta, during March–August 2019. Results: There were 62 subjects, with a median age of 66 years, 56.5% male. The result showed that most of the patients have a good QoL, based on each domain of SF-36 and EORTC QLQ-C30. In multivariate analysis, it was found that depression and frailty status were related to PCS SF-36 domain with PR 12.086 (95% CI 1.596–92.124) and PR 5.622 (95% CI 1.060–29.807), respectively. Multivariate analysis with SF-36's Mental Component Summary (MCS) showed a significant relationship with depression status with PR 24.400 (95% CI 2.961–140.539). While the results of multivariate analysis with the EORTC QLQ-C30 functional scale showed a significant relationship with the ECOG performance score with PR 171 (95% CI 8.470–3452.28). Discussions: After multivariate analysis, only frailty status, depression status and ECOG performance score have a statistically significant relationship. © 2020 Elsevier Ltd |
|
antineoplastic agent; cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine; Abbreviated Mental Test; adult; aged; Barthel index; Barthel Index Activities of Daily Living; body mass; cancer chemotherapy; cancer survivor; clinical evaluation; comorbidity; controlled study; cross-sectional study; Cumulative Illness Rating for Geriatrics; Cumulative Illness Rating Scale; demography; diffuse large B cell lymphoma; ECOG Performance Status; European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; female; geriatric assessment; Geriatric Depression Scale; human; Indonesia; Karnofsky Performance Status; Lawton instrumental activities of daily living scale; Letter; major clinical study; male; mental test; middle aged; Mini Nutrit |
Elsevier Ltd |
18794068 |
|
33008767 |
Letter |
Q2 |
1032 |
4192 |
|
|
557 |
Della C.D., Teo D.C.L., Agiananda F., Nimnuan C. |
57200945999;57192839106;55644397300;6506165703; |
Culturally informed psychotherapy in Asian consultation-liaison psychiatry |
2021 |
Asia-Pacific Psychiatry |
13 |
1 |
e12431 |
|
|
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092615807&doi=10.1111%2fappy.12431&partnerID=40&md5=1d13ff58ccac52f58bf302293a14868b |
College of Medicine, University of the Philippines Manila, Philippine General Hospital, Manila, Philippines; Department of Psychological Medicine, Changi General Hospital, Duke-NUS Medical School, Singapore; Faculty of Medicine, Department of Psychiatry, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta Pusat, Indonesia; Faculty of Medicine, Chulalongkorn University, Thailand |
Della, C.D., College of Medicine, University of the Philippines Manila, Philippine General Hospital, Manila, Philippines; Teo, D.C.L., Department of Psychological Medicine, Changi General Hospital, Duke-NUS Medical School, Singapore; Agiananda, F., Faculty of Medicine, Department of Psychiatry, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta Pusat, Indonesia; Nimnuan, C., Faculty of Medicine, Chulalongkorn University, Thailand |
Psychotherapy provides substantial benefits for patients with medical illness. Western-based psychotherapies are commonly practiced by consultation-liaison psychiatrists in Asia. Although such interventions benefit Asian patients, they are limited by their cultural applicability. Sociocultural factors shape the meaning, expression, and treatment of medical illnesses. In helping patients with medical problems, it is imperative that psychiatrists be mindful of the value of culture in their clinical work. The concept of the self, religion, spirituality, adaptation, coping, and defense mechanisms are all culturally determined. This article discusses how these concepts impact the practice of psychotherapy in the Asian consultation-liaison psychiatry setting. Currently, there is a dearth of systematic research about this subject matter. Most studies describe the application of Western-based psychotherapies for patients with medical illness with little input as to cultural modifications or implications of such interventions. The authors of this article identify culturally consonant psychotherapeutic techniques in the Asian consultation-liaison psychiatry context. Furthermore, they also propose general guidelines in the cultural adaptation of psychotherapy interventions or development of indigenous psychotherapies. © 2020 John Wiley & Sons Australia, Ltd |
collectivism; consultation-liaison psychiatry; culture; psychotherapy; religion |
adult; article; Asia; Asian; consonant; consultation; defense mechanism; human; liaison psychiatry; practice guideline; psychiatrist; psychotherapy; religion; mental disease; patient referral; procedures; psychotherapy; transcultural care; Asia; Culturally Competent Care; Humans; Mental Disorders; Psychotherapy; Referral and Consultation |
Wiley-Blackwell |
17585864 |
|
33073528 |
Article |
Q2 |
654 |
7658 |
|
|
558 |
Pranata R., Lim M.A., Yonas E., Vania R., Lukito A.A., Siswanto B.B., Meyer M. |
57201973901;57216039756;57201987097;57208328436;57213835420;14422648800;57217373886; |
Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis |
2021 |
Diabetes and Metabolism |
47 |
2 |
101178 |
|
|
|
76 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089283809&doi=10.1016%2fj.diabet.2020.07.005&partnerID=40&md5=a6503da65fb4a1f9b97a1b42e95385cf |
Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Department of Cardiology and Vascular Medicine, Siloam Hospitals Lippo Village, Tangerang, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia |
Pranata, R., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Lim, M.A., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Yonas, E., Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Vania, R., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Lukito, A.A., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia, Department of Cardiology and Vascular Medicine, Siloam Hospitals Lippo Village, Tangerang, Indonesia; Siswanto, B.B., Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Meyer, M., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia |
Background: There is mounting evidence related to the association between obesity and severity of COVID-19. However, the direct relationship of the increase in the severe COVID-19 risk factors, with an increase in body mass index (BMI), has not yet been evaluated. Aim: This meta-analysis aims to evaluate the dose–response relationship between body mass index (BMI) and poor outcome in patients with COVID-19. Methods: A systematic literature search was conducted using PubMed, Europe PMC, ProQuest, and the Cochrane Central Database. The primary outcome was composite poor outcome composed of mortality and severity. The secondary outcomes were mortality and severity. Results: A total of 34,390 patients from 12 studies were included in this meta-analysis. The meta-analysis demonstrated that obesity was associated with composite poor outcome (OR 1.73 [1.40, 2.14], P < 0.001; I2: 55.6%), mortality (OR 1.55 [1.16, 2.06], P = 0.003; I2: 74.4%), and severity (OR 1.90 [1.45, 2.48], P < 0.001; I2: 5.2%) in patients with COVID-19. A pooled analysis of highest BMI versus reference BMI indicate that a higher BMI in the patients was associated with composite poor outcome (aOR 3.02 [1.82, 5.00], P < 0.001; I2: 59.8%), mortality (aOR 2.85 [1.17, 6.92], P = 0.002; I2: 79.7%), and severity (aOR 3.08 [1.78, 5.33], P < 0.001; I2: 11.7%). The dose–response meta-analysis showed an increased risk of composite poor outcome by aOR of 1.052 [1.028, 1.077], P < 0.001 for every 5 kg/m2 increase in BMI (Pnon-linearity < 0.001). The curve became steeper with increasing BMI. Conclusion: Dose–response meta-analysis demonstrated that increased BMI was associated with increased poor outcome in patients with COVID-19. © 2020 Elsevier Masson SAS |
Body mass index; Coronavirus; Obesity; SARS-CoV-2; Weight |
antidiabetic agent; antihypertensive agent; adult; aged; antihypertensive therapy; Article; body mass; clinical outcome; coronavirus disease 2019; diabetes mellitus; disease severity; dose response; female; human; hypertension; male; meta analysis; mortality rate; obesity; risk assessment; systematic review; body mass; complication; middle aged; obesity; risk factor; severity of illness index; therapy; treatment outcome; Aged; Body Mass Index; COVID-19; Female; Humans; Male; Middle Aged; Obesity; Risk Factors; SARS-CoV-2; Severity of Illness Index; Treatment Outcome |
Elsevier Masson s.r.l. |
12623636 |
|
32738402 |
Article |
Q1 |
1480 |
2328 |
|
|
559 |
Kesuma Y., Sekartini R., Timan I.S., Kurniawan A., Bardosono S., Firmansyah A., Vandenplas Y. |
57209278648;57224503576;6602793366;6506883360;21933841000;6602915502;57223670656; |
Irritable bowel syndrome in Indonesian adolescents |
2021 |
Jornal de Pediatria |
97 |
2 |
|
197 |
203 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081734309&doi=10.1016%2fj.jped.2020.02.001&partnerID=40&md5=b8d2dcd5c96832dce29f4c05c71dd219 |
Sriwijaya University and Moh Hoesin Hospital, Faculty of Medicine, Department of Pediatrics, Palembang, Indonesia; University of Indonesia and Cipto Mangunkusumo Hospital, Faculty of Medicine, Department of Pediatrics, Jakarta, Indonesia; University of Indonesia Cipto Mangunkusumo Hospital, Faculty of Medicine, Department of Clinical Pathology, Jakarta, Indonesia; University of Indonesia, Faculty of Medicine, Department of Parasitology, Jakarta, Indonesia; University of Indonesia, Faculty of Medicine, Department of Nutrition, Jakarta, Indonesia; Free University of Brussels, UZ Brussel Hospital, KidZ Health Castle, Brussels, Belgium |
Kesuma, Y., Sriwijaya University and Moh Hoesin Hospital, Faculty of Medicine, Department of Pediatrics, Palembang, Indonesia; Sekartini, R., University of Indonesia and Cipto Mangunkusumo Hospital, Faculty of Medicine, Department of Pediatrics, Jakarta, Indonesia; Timan, I.S., University of Indonesia Cipto Mangunkusumo Hospital, Faculty of Medicine, Department of Clinical Pathology, Jakarta, Indonesia; Kurniawan, A., University of Indonesia, Faculty of Medicine, Department of Parasitology, Jakarta, Indonesia, University of Indonesia, Faculty of Medicine, Department of Nutrition, Jakarta, Indonesia; Bardosono, S., University of Indonesia, Faculty of Medicine, Department of Nutrition, Jakarta, Indonesia; Firmansyah, A., University of Indonesia and Cipto Mangunkusumo Hospital, Faculty of Medicine, Department of Pediatrics, Jakarta, Indonesia; Vandenplas, Y., Free University of Brussels, UZ Brussel Hospital, KidZ Health Castle, Brussels, Belgium |
Objective: Irritable bowel syndrome is a frequent functional gastrointestinal disorder. The aims of this study were to investigate its epidemiology, focusing on the role of intestinal mucosal integrity and to evaluate the impact on the quality of life. Methods: A community-based survey applying a comparative cross sectional approach was conducted in six high schools in Palembang. Subjects were recruited using multistage random sampling divided in two groups. Rome III criteria were used to establish a diagnosis of IBS in combination with a questionnaire to determine risk factors. Determination of fecal alpha-1-antitrypsin and calprotectin levels was performed to determine impaired intestinal mucosal integrity. A questionnaire was used to evaluate how quality of life was affected by irritable bowel syndrome. Results: The survey was performed in 454 14−18 years old adolescents, of whom 30.2% fulfilled the Rome III criteria for IBS, with the following subtypes: 36.5% diarrhea, 18.9% constipation, 21.9% mixed, and 22.6% unclassified. Major risk factors were female gender, bullying, age 14–16 years, history of constipation and diarrhea, eating nuts, and drinking coffee, tea, and soft drinks. There was a significant association with intestinal inflammation (p = 0.013). A significantly impaired quality of life was found (p = 0.001). Conclusions: The prevalence of irritable bowel syndrome in adolescents was high, with bullying, female gender, age 14–16 years, constipation and diarrhea, and dietary consumption of soft drinks, coffee, and tea as risk factors. A significant association with intestinal inflammation was found. © 2020 Sociedade Brasileira de Pediatria |
Adolescent; Intestinal integrity; Irritable bowel syndrome; Quality of life |
alpha 1 antitrypsin; calgranulin; adolescent; adult; age; Article; avoidance behavior; body image; bullying; clinical evaluation; coffee consumption; comparative study; constipation; controlled study; cross-sectional study; data analysis software; diarrhea; digestive system disease assessment; disease association; dysphoria; enteritis; feces level; female; gender; high school; human; human activities; human relation; Indonesia; Indonesian; intestine mucosa; Irritable Bowel Syndrome Quality of Life questionnaire; irritable colon; major clinical study; male; nut; patient worry; pediatric patient; prevalence; quality of life; quality of life assessment; risk factor; Rome III criteria; sexual behavior; social behavior; soft drink; tea consumption; constipation; irritable colon; questionnaire; |
Elsevier Editora Ltda |
00217557 |
|
32156535 |
Article |
Q2 |
645 |
7804 |
|
|
560 |
Purbadi S., Saspriyana K.Y. |
6505677307;57215693910; |
Primary debulking surgery of advanced epithelial ovarian cancer in developing countries: Challenges and expectations |
2021 |
European Journal of Gynaecological Oncology |
42 |
1 |
|
26 |
29 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101075370&doi=10.31083%2fj.ejgo.2021.01.2230&partnerID=40&md5=7e3562ded7816ae8267f39ec3c207282 |
Gynaecology Oncology Division, Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta, 10430, Indonesia; Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, 80113, Indonesia |
Purbadi, S., Gynaecology Oncology Division, Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta, 10430, Indonesia; Saspriyana, K.Y., Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia, Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, 80113, Indonesia |
Ovarian cancer often presents itself in advanced stages and can be accompanied by various comorbidities. Treatment options are primary debulking surgery (PDS) followed by adjuvant chemotherapy, or alternatively, neoadjuvant chemotherapy followed by interval debulking surgery (IDS). The option taken is based on several considerations. If the patient can be treated with PDS, the absence of macroscopic residual disease becomes an independent prognostic factor. However, achieving this outcome is a challenge for the gynaecologic oncologist since advanced stage ovarian cancer generally metastasizes into the peritoneum and the upper abdominal organs. Optimal outcomes are that surgery will be safe for the patient, no macroscopic residual disease is achieved, minimal postoperative complications are encountered, and a good survival rate is obtained. Developed countries, especially Europe, have well-recognized standards of care which are followed by developing countries; however, challenges with insurance coverage and inter-departmental cooperation are recognized hurdles in developing countries. Competency improvement along with good inter-departmental communication and collaboration are keys to optimal outcomes for PDS. © 2021 The Authors. Published by IMR Press. |
Competency; Interdepartmental approach; Ovarian cancer; Primary debulking surgery; Residual disease |
abdominal viscera; cancer prognosis; cancer staging; cytoreductive surgery; developing country; Europe; European; female; health insurance; human; intersectoral collaboration; learning; medical society; minimal residual disease; outcome assessment; ovary carcinoma; peritoneum metastasis; postoperative complication; public-private partnership; Review; survival rate |
IMR Press Limited |
03922936 |
|
|
Review |
Q4 |
150 |
23157 |
|
|